These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6885106)

  • 1. Level of macrophage induction during tumor growth: primed or activated?
    Burger CJ; Elgert KD
    Immunol Commun; 1983; 12(3):285-90. PubMed ID: 6885106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide.
    Mullins DW; Burger CJ; Elgert KD
    J Immunol; 1999 Jun; 162(11):6811-8. PubMed ID: 10352302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activation states of tumor-associated and peritoneal macrophages from mice bearing an induced fibrosarcoma.
    Valdez JC; de Alderete N; Meson OE; Sirena A; Perdigon G
    Immunobiology; 1990 Nov; 181(4-5):276-87. PubMed ID: 2099903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor growth modulates macrophage nitric oxide production following paclitaxel administration.
    Mullins DW; Burger CJ; Elgert KD
    Int J Immunopharmacol; 1998 Oct; 20(10):537-51. PubMed ID: 9839658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage mediated tumor cell cytotoxicity.
    Kaplan AM; Morahan PS
    Ann N Y Acad Sci; 1976; 276():134-45. PubMed ID: 1071961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.
    Mullins DW; Walker TM; Burger CJ; Elgert KD
    Cancer Immunol Immunother; 1997 Oct; 45(1):20-8. PubMed ID: 9353423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum.
    Basić I; Milas L; Grdina DJ; Withers HR
    J Natl Cancer Inst; 1975 Sep; 55(3):589-96. PubMed ID: 1159835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of PSK on the recovery of macrophage function and T cell-mediated immunity in tumor-bearing mice].
    Tsuru S; Taniguchi M; Zinnaka Y; Nomoto K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2375-80. PubMed ID: 6333849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and functional characterization of three activated macrophage populations.
    Edwards JP; Zhang X; Frauwirth KA; Mosser DM
    J Leukoc Biol; 2006 Dec; 80(6):1298-307. PubMed ID: 16905575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas.
    Russell SW; Gillespie GY; McIntosh AT
    J Immunol; 1977 May; 118(5):1574-9. PubMed ID: 870561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors.
    Russell SW; Doe WF; McIntosh AT
    J Exp Med; 1977 Dec; 146(6):1511-20. PubMed ID: 925611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of immunity against solid fibrosarcoma in mice with splenocytes and peritoneal exudate cells obtained after in vitro sensitization and in vivo immunization with cis-dichlorodiamine platinum(II) treated fibrosarcoma cells.
    Sodhi A; Tandon P; Sarna S
    Arch Geschwulstforsch; 1985; 55(1):47-61. PubMed ID: 3872651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages.
    Decker T; Lohmann-Matthes ML; Karck U; Peters T; Decker K
    J Leukoc Biol; 1989 Feb; 45(2):139-46. PubMed ID: 2783725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherent cells (macrophages?) in tumor-bearing mice suppress MLC responses.
    Garrigues HJ; Romero P; Hellström I; Hellström KE
    Cell Immunol; 1981 May; 60(1):109-18. PubMed ID: 6453654
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R; Nacy CA; Eisenstein TK
    J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of tumor growth by peritoneal macrophages of normal and tumor-bearing mice.
    Gabizon A; Trainin N
    Adv Exp Med Biol; 1979; 121B():485-91. PubMed ID: 317562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice.
    Elgert KD; Connolly KM
    Oncology; 1980; 37(2):101-6. PubMed ID: 6444706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities.
    Reiter I; Krammer B; Schwamberger G
    J Immunol; 1999 Aug; 163(4):1730-2. PubMed ID: 10438900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects on tumor cells of macrophages isolated from an early-passage chemically-induced murine sarcoma and from its spontaneous metastases.
    Mantovani A
    Int J Cancer; 1981 Feb; 27(2):221-8. PubMed ID: 7287217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.